查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434308

自動化和閉式細胞治療處理系統市場：按工作流程、類型和規模 - 2024-2030 年全球預測

Automated & Closed Cell Therapy Processing Systems Market by Workflow (Apheresis, Cryopreservation, Expansion), Type (Non-Stem Cell Therapy, Stem Cell Therapy), Scale - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年自動化和閉式細胞治療處理系統市場規模為94394萬美元，2024年達到108797萬美元，2030年達到262676萬美元，複合年成長率為15.74%。

自動化和封閉式細胞治療處理系統的全球市場

主要市場統計
基準年[2023] 94394萬美元
預測年份 [2024] 1,087,970,000 美元
預測年份 [2030] 26.2676億美元
複合年成長率（%） 15.74%
自動化和閉式細胞治療處理系統市場-IMG1

FPNV定位矩陣

FPNV 定位矩陣對於評估自動化和封閉式細胞治療處理系統市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對自動化和閉式細胞治療處理系統市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-自動化和閉式細胞治療處理系統市場的市場規模和預測是多少？

2-在自動化和閉式細胞治療處理系統市場的預測期內，需要考慮投資的產品、細分市場、應用和領域有哪些？

3-自動化和閉式細胞治療處理系統市場的技術趨勢和法律規範是什麼？

4-自動化和閉式細胞治療處理系統市場主要供應商的市場佔有率是多少？

5-進入自動化和閉式細胞治療處理系統市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 再生醫學和細胞療法日益普及
      • 對具有成本效益的個人化藥物的需求不斷成長
      • 自動化系統相對於手動處理的操作優勢
    • 抑制因素
      • 與不同治療方法相關的生物學變異
    • 機會
      • 促進自動化細胞治療處理系統的研發活動
      • 先進治療方法開發程序和軟體技術的整合
    • 任務
      • 缺乏熟練的專業人員和複雜的自動化流程
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章自動化和閉式細胞治療處理系統市場：依工作流程

  • 血漿分離術
  • 冷凍儲藏
  • 擴張
  • 填充/整理
  • 分離

第7章自動化和閉式細胞治療處理系統市場：按類型

  • 非幹細胞療法
  • 幹細胞療法

第8章自動化和閉式細胞治療處理系統市場：按規模

  • 商業規模
  • 預商業或研發規模

第9章美洲自動化和閉式細胞治療處理系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區自動化與閉孔治療處理系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲自動化與封閉細胞治療處理系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：按主要企業分類
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • Bio-Techne Corporation
    • BioLife Solutions Inc.
    • BioSpherix, Ltd.
    • Cellares Inc.
    • Corning Incorporated
    • Cytiva
    • Danaher Corporation
    • Fresenius SE & Co. KGaA
    • General Electric Company
    • Lonza Group AG
    • Merck KGaA
    • Miltenyi Biotec BV & Co. KG
    • Novartis AG
    • Pluristem Therapeutics Inc.
    • Regeneus Ltd.
    • Sartorius AG
    • STEMCELL Technologies Canada Inc.
    • Terumo Corporation
    • Thermo Fisher Scientific, Inc.
    • Thermogenesis Holdings, Inc.
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-3A2E844FE4F9

[186 Pages Report] The Automated & Closed Cell Therapy Processing Systems Market size was estimated at USD 943.94 million in 2023 and expected to reach USD 1,087.97 million in 2024, at a CAGR 15.74% to reach USD 2,626.76 million by 2030.

Global Automated & Closed Cell Therapy Processing Systems Market

KEY MARKET STATISTICS
Base Year [2023] USD 943.94 million
Estimated Year [2024] USD 1,087.97 million
Forecast Year [2030] USD 2,626.76 million
CAGR (%) 15.74%
Automated & Closed Cell Therapy Processing Systems Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Automated & Closed Cell Therapy Processing Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Automated & Closed Cell Therapy Processing Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Automated & Closed Cell Therapy Processing Systems Market, highlighting leading vendors and their innovative profiles. These include Bio-Techne Corporation, BioLife Solutions Inc., BioSpherix, Ltd., Cellares Inc., Corning Incorporated, Cytiva, Danaher Corporation, Fresenius SE & Co. KGaA, General Electric Company, Lonza Group AG, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Pluristem Therapeutics Inc., Regeneus Ltd., Sartorius AG, STEMCELL Technologies Canada Inc., Terumo Corporation, Thermo Fisher Scientific, Inc., and Thermogenesis Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Automated & Closed Cell Therapy Processing Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Workflow
    • Apheresis
    • Cryopreservation
    • Expansion
    • Fill- Finish
    • Separation
  • Type
    • Non-Stem Cell Therapy
    • Stem Cell Therapy
  • Scale
    • Commercial Scale
    • Pre-commercial or R&D Scale
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Automated & Closed Cell Therapy Processing Systems Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Automated & Closed Cell Therapy Processing Systems Market?

3. What are the technology trends and regulatory frameworks in the Automated & Closed Cell Therapy Processing Systems Market?

4. What is the market share of the leading vendors in the Automated & Closed Cell Therapy Processing Systems Market?

5. Which modes and strategic moves are suitable for entering the Automated & Closed Cell Therapy Processing Systems Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Automated & Closed Cell Therapy Processing Systems Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising popularity of regenerative medicines & cell therapies
      • 5.1.1.2. Growing need for cost-effective and personalized drugs
      • 5.1.1.3. Operational superiority of automated systems over manual processing
    • 5.1.2. Restraints
      • 5.1.2.1. Biological variations associated with different therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancing research and development activities in automated cell therapy processing systems
      • 5.1.3.2. Integration of advanced therapy development procedures and software technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals and complicated process of automation
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Automated & Closed Cell Therapy Processing Systems Market, by Workflow

  • 6.1. Introduction
  • 6.2. Apheresis
  • 6.3. Cryopreservation
  • 6.4. Expansion
  • 6.5. Fill- Finish
  • 6.6. Separation

7. Automated & Closed Cell Therapy Processing Systems Market, by Type

  • 7.1. Introduction
  • 7.2. Non-Stem Cell Therapy
  • 7.3. Stem Cell Therapy

8. Automated & Closed Cell Therapy Processing Systems Market, by Scale

  • 8.1. Introduction
  • 8.2. Commercial Scale
  • 8.3. Pre-commercial or R&D Scale

9. Americas Automated & Closed Cell Therapy Processing Systems Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Automated & Closed Cell Therapy Processing Systems Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Automated & Closed Cell Therapy Processing Systems Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Bio-Techne Corporation
    • 13.1.2. BioLife Solutions Inc.
    • 13.1.3. BioSpherix, Ltd.
    • 13.1.4. Cellares Inc.
    • 13.1.5. Corning Incorporated
    • 13.1.6. Cytiva
    • 13.1.7. Danaher Corporation
    • 13.1.8. Fresenius SE & Co. KGaA
    • 13.1.9. General Electric Company
    • 13.1.10. Lonza Group AG
    • 13.1.11. Merck KGaA
    • 13.1.12. Miltenyi Biotec B.V. & Co. KG
    • 13.1.13. Novartis AG
    • 13.1.14. Pluristem Therapeutics Inc.
    • 13.1.15. Regeneus Ltd.
    • 13.1.16. Sartorius AG
    • 13.1.17. STEMCELL Technologies Canada Inc.
    • 13.1.18. Terumo Corporation
    • 13.1.19. Thermo Fisher Scientific, Inc.
    • 13.1.20. Thermogenesis Holdings, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET DYNAMICS
  • FIGURE 7. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 8. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2023 VS 2030 (%)
  • FIGURE 12. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 6. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APHERESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY EXPANSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILL- FINISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SEPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY NON-STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 15. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRE-COMMERCIAL OR R&D SCALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
  • TABLE 144. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 145. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET LICENSE & PRICING